FOLH1 and neoplasm: In the three patients eligible for [177Lu]Lu-PSMA therapy, PSMA staining exhibited a higher H-score of 65 (62.5-77.5) in endothelial cells compared to 30 (17.5-52.5) in the patients who were not eligible for [177Lu]Lu-PSMA therapy (p = 0.08) and a linear regression analysis showed a trend for higher endothelial but not tumor cell PSMA expression in patients with increased [68Ga]Ga-PSMA uptake (Figure 2).